Campath dosing suspended in phase II trial: cases of severe ITP

By  

Reactions Weekly, Vol. 1, Iss. 1070, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

DOV Pharmaceuticals has announced that dosing has been suspended in its ongoing trial of ocinaplon due to liver enzyme elevations

By  

Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Dosing and Switching Strategies for Paliperidone Palmitate: Based on Population Pharmacokinetic Modelling and Clinical Trial Data

By Samtani Mahesh N.  

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 829-845

Adis International

Access to resources Recommend Favorite

Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules

By Burstein Harold   Overmoyer Beth   Gelman Rebecca   Silverman Paula   Savoie Jennifer   Clarke Kathryn   Dumadag Leda   Younger Jerry   Ivy Percy   Winer Eric  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 161-164

Springer Publishing Company

Access to resources Recommend Favorite

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

By van Schie Rianne MF   Wadelius Mia   Kamali Farhad   Daly Ann K   Manolopoulos Vangelis G   de Boer Anthonius   Barallon Rita   Verhoef Talitha I   Kirchheiner Julia   Haschke-Becher Elisabeth   Briz Montserrat   Rosendaal Frits R   Redekop William K   Pirmohamed Munir   Maitland-van der Zee Anke-Hilse  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1687-1695

Future Medicine

Access to resources Recommend Favorite